![Larry C. Fritz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Larry C. Fritz first degree
Entity | Entity type | Industry | |
---|---|---|---|
Conforma Therapeutics Corp.
![]() Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Larry C. Fritz via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Lipid Sciences, Inc.
![]() Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Archimedes Technology Group Holdings LLC
![]() Archimedes Technology Group Holdings LLC Medical SpecialtiesHealth Technology Archimedes Technology Group Holdings LLC researches and develops medical instruments such as plasma ion separation systems. The firm provides products such as environmental research laboratory, measuring, observing, and testing equipment. It serves the medical, semiconductor, and nuclear power industries. The company was founded in 1998 and is located in San Diego, CA. | Medical Specialties | Corporate Officer/Principal | |
Idun Pharmaceuticals, Inc.
![]() Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Corporate Officer/Principal | |
GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Director/Board Member | |
NovaCardia, Inc.
![]() NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Cabrellis Pharmaceuticals Corp.
![]() Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Founder | |
TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Retirement Inns of America, Inc. | Comptroller/Controller/Auditor | ||
RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO | |
Viamet Pharmaceuticals Corp.
![]() Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Esanex, Inc.
![]() Esanex, Inc. Pharmaceuticals: MajorHealth Technology Esanex, Inc. manufactures and develops drugs for cancer treatment. Its products include orally active Hsp90 inhibitors. The company was founded in 2011 and is headquartered in Indianapolis, IN. | Pharmaceuticals: Major | Director/Board Member | |
Innocrin Pharmaceuticals Holdings LLC
![]() Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
Domain Associates LLC
![]() Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Consultant / Advisor | |
MCA, Inc.
![]() MCA, Inc. Movies/EntertainmentConsumer Services MCA, Inc. is based in Universal City, CA. Part of Panasonic Holdings Corp., MCA, Inc. is a company that produces films and television programs and publishes music. MCA was acquired by Panasonic Holdings Corp. on January 03, 1991 for $6,588.80 million. | Movies/Entertainment | Comptroller/Controller/Auditor | |
Chiron Viagene, Inc.
![]() Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genetic Engineering, Inc.
![]() Genetic Engineering, Inc. Agricultural Commodities/MillingProcess Industries Part of Healthier Choices Management Corp., Genetic Engineering, Inc. is a biotechnology company that specializes in bovine genetics. The company is based in Denver, CO. Genetic Engineering was acquired by Miller Diversified Corp. on May 18, 1992. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
MIRATI THERAPEUTICS | Biotechnology | Corporate Officer/Principal | |
Stony Brook University | College/University | Doctorate Degree | |
Drake University | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
University of California San Diego | College/University | Undergraduate Degree | |
University of Bristol | College/University | Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Corporate Officer/Principal | |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Kent SeaTech Corp. | Director of Finance/CFO | ||
Stephen M. Ross School of Business | College/University | Masters Business Admin | |
Lilly Ventures Fund I LLC
![]() Lilly Ventures Fund I LLC Investment ManagersFinance Lilly Ventures Fund I LLC seeks investment opportunities located in the North American and European regions. The fund targets companies operating in the fields of biotechnology, medical technology and healthcare IT. It provides financing for early stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kellogg School of Management | College/University | Masters Business Admin | |
StemoniX, Inc.
![]() StemoniX, Inc. Miscellaneous Commercial ServicesCommercial Services StemoniX, Inc. provides IPS-based platforms for pharmacy and research institutions. It offers microBrain 3D Assay Ready, microBrain 2D Assay Ready, microPlate, microHeart Assay Ready, and microHeart Cell Ready. The company was founded by Yung-Ping Yeh and Robert Petcavich in 2014 and is headquartered in Maple Grove, MN. | Miscellaneous Commercial Services | Director/Board Member | |
January Therapeutics, Inc.
![]() January Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services January Therapeutics, Inc. provides biotechnology services. The company was founded by Robin Jackman and Neil Raheja and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Escient Pharmaceuticals, Inc.
![]() Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Founder | |
UC San Diego Foundation
![]() UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
VYANT BIO, INC. | Biotechnology | Director/Board Member | |
Xinthera, Inc.
![]() Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Chief Executive Officer | |
Vioplore Management LLC | Private Equity Investor | ||
Innocrin Pharmaceuticals, Inc.
![]() Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 49 |
Italy | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 10 |
Commercial Services | 7 |
Finance | 3 |
Health Services | 2 |
Operational
Director/Board Member | 52 |
Corporate Officer/Principal | 38 |
Founder | 20 |
Chief Executive Officer | 17 |
Chairman | 13 |
Most connected contacts
Insiders | |
---|---|
Eckard Weber | 46 |
S. Torres | 21 |
Chris LeMasters | 15 |
John E. Crawford | 13 |
Marcus F. Boehm | 10 |
James R. Schmidt | 9 |
Casey Logan | 8 |
Michael A. Adam | 7 |
Robert L. de Jager | 7 |
Francis Burrows | 7 |
Devron R. Averett | 6 |
- Stock Market
- Insiders
- Larry C. Fritz
- Company connections